![Frank Gleeson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Gleeson
Founder at
SATELLOS BIOSCIENCE INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Frank Gleeson is the founder of Verio Therapeutics, Inc., founded in 2008.
Mr. Gleeson was the founder of Satellos Bioscience, Inc., founded in 2018, and held the title President & Chief Executive Officer.
Mr. Gleeson is the founder of Satellos Bioscience, Inc., founded in 2012, and holds the titles President, Chief Executive Officer & Director since 2018.
Mr. Gleeson is also the founder of Gleeson & Associates,Canadian Glycomics Network..
Mr. Gleeson was Chief Executive Officer at MDS Proteomics, Inc. from 1999 to 2003.
Mr. Gleeson was Chairman at Stem Cell Network.
Mr. Gleeson was Director at Privacy Analytics, Inc. Mr. Gleeson was Senior Vice President at Mercal Capital Corp.
Mr. Gleeson completed undergraduate and MBA degrees at York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/04/2026 | 331,365 ( 1.59% ) | 2 M $ | 31/05/2026 |
Frank Gleeson active positions
| Companies | Position | Start |
|---|---|---|
| SATELLOS BIOSCIENCE INC. | Founder | 01/07/2012 |
Gleeson & Associates | Founder | - |
Former positions of Frank Gleeson
| Companies | Position | End |
|---|---|---|
MDS Proteomics, Inc.
 MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Chief Executive Officer | 01/01/2003 |
Canadian Glycomics Network
 Canadian Glycomics Network BiotechnologyHealth Technology Develops new carbohydrate-based drugs, vaccines and diagnostics | Founder | - |
Verio Therapeutics, Inc.
 Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells | Founder | - |
Stem Cell Network
 Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services | Chairman | - |
Satellos Bioscience, Inc. /Old/
 Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Chief Executive Officer | - |
Training of Frank Gleeson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
6
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
MDS Proteomics, Inc.
MDS Proteomics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and analyzes proteins to determine their role in disease | Commercial Services |
York University
 York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verio Therapeutics, Inc.
Verio Therapeutics, Inc. BiotechnologyHealth Technology Manufactures pharmaceutical products for activating endogenous stem cells | Health Technology |
Privacy Analytics, Inc.
 Privacy Analytics, Inc. Packaged SoftwareTechnology Services Develops software for protecting the privacy of personal data used for analysis and research | Technology Services |
Mercal Capital Corp.
 Mercal Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Gleeson & Associates | |
Satellos Bioscience, Inc. /Old/
Satellos Bioscience, Inc. /Old/ BiotechnologyHealth Technology Engages in research and development of stem cell regeneration | Health Technology |
Stem Cell Network
Stem Cell Network Miscellaneous Commercial ServicesCommercial Services Engages in research & development and offers funding for stem cell regenerative medicine and provides training services | Commercial Services |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Canadian Glycomics Network
Canadian Glycomics Network BiotechnologyHealth Technology Develops new carbohydrate-based drugs, vaccines and diagnostics | Health Technology |
- Stock Market
- Insiders
- Frank Gleeson
